Privia Health Group Past Earnings Performance
Past criteria checks 3/6
Privia Health Group has been growing earnings at an average annual rate of 10.2%, while the Healthcare industry saw earnings growing at 7% annually. Revenues have been growing at an average rate of 19.4% per year. Privia Health Group's return on equity is 3.5%, and it has net margins of 1.4%.
Key information
10.2%
Earnings growth rate
9.5%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 19.4% |
| Return on equity | 3.5% |
| Net Margin | 1.4% |
| Next Earnings Update | 09 May 2024 |
Recent past performance updates
Recent updates
Analysts Just Slashed Their Privia Health Group, Inc. (NASDAQ:PRVA) EPS Numbers
Mar 03
The Price Is Right For Privia Health Group, Inc. (NASDAQ:PRVA)
Feb 27There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital
Jan 31Why Privia Health Group, Inc. (NASDAQ:PRVA) Could Be Worth Watching
Dec 03Privia Health Group, Inc.'s (NASDAQ:PRVA) Price In Tune With Revenues
Nov 06Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business
Aug 08Privia Health Group, Inc. (NASDAQ:PRVA) Shares Could Be 48% Below Their Intrinsic Value Estimate
Mar 17Privia Health: In Line For Solid FY22, Hold On Valuation
Sep 15Privia Health Group reports Q2 earnings beat; raises FY22 outlook
Aug 11Privia Health Group Grows But Operating Results Await
Jun 20Is Privia Health Group, Inc. (NASDAQ:PRVA) Trading At A 48% Discount?
Feb 09Privia Health Group: Not Healthy Yet
Feb 06A Look At The Fair Value Of Privia Health Group, Inc. (NASDAQ:PRVA)
Nov 11Calculating The Intrinsic Value Of Privia Health Group, Inc. (NASDAQ:PRVA)
Jul 29Privia Health Group, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 28Disrupting Healthcare - IPO Interview With Privia Health CEO Shawn Morris (Video)
May 03Privia Health Group: Good Intentions Do Not Automatically Make A Good Investment
May 01Revenue & Expenses BreakdownBeta
How Privia Health Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,658 | 23 | 133 | 0 |
| 30 Sep 23 | 1,581 | 38 | 132 | 0 |
| 30 Jun 23 | 1,507 | 34 | 135 | 0 |
| 31 Mar 23 | 1,429 | 16 | 140 | 0 |
| 31 Dec 22 | 1,357 | -9 | 146 | 0 |
| 30 Sep 22 | 1,268 | -38 | 159 | 0 |
| 30 Jun 22 | 1,176 | -49 | 160 | 0 |
| 31 Mar 22 | 1,066 | -211 | 302 | 0 |
| 31 Dec 21 | 966 | -188 | 279 | 0 |
| 30 Sep 21 | 905 | -172 | 254 | 0 |
| 30 Jun 21 | 860 | -147 | 228 | 0 |
| 31 Mar 21 | 818 | 31 | 59 | 0 |
| 31 Dec 20 | 817 | 31 | 55 | 0 |
| 31 Dec 19 | 786 | 8 | 51 | 0 |
| 31 Dec 18 | 658 | -3 | 53 | 0 |
Quality Earnings: PRVA has high quality earnings.
Growing Profit Margin: PRVA became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PRVA has become profitable over the past 5 years, growing earnings by 10.2% per year.
Accelerating Growth: PRVA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: PRVA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (9.2%).
Return on Equity
High ROE: PRVA's Return on Equity (3.5%) is considered low.